Literature DB >> 22914647

Mitotically inactivated embryonic stem cells can be used as an in vivo feeder layer to nurse damaged myocardium after acute myocardial infarction: a preclinical study.

Richard K Burt1, You-hong Chen, Larissa Verda, Carolina Lucena, Shankararao Navale, Jesse Johnson, Xiaoqiang Han, Jon Lomasney, Jessa M Baker, Ka-Leung Ngai, Aya Kino, James Carr, Jan Kajstura, Piero Anversa.   

Abstract

RATIONALE: Various types of viable stem cells have been reported to result in modest improvement in cardiac function after acute myocardial infarction. The mechanisms for improvement from different stem cell populations remain unknown.
OBJECTIVE: To determine whether irradiated (nonviable) embryonic stem cells (iESCs) improve postischemic cardiac function without adverse consequences. METHODS AND
RESULTS: After coronary artery ligation-induced cardiac infarction, either conditioned media or male murine or male human iESCs were injected into the penumbra of ischemic myocardial tissue of female mice or female rhesus macaque monkeys, respectively. Murine and human iESCs, despite irradiation doses that prevented proliferation and induced cell death, significantly improved cardiac function and decreased infarct size compared with untreated or media-treated controls. Fluorescent in situ hybridization of the Y chromosome revealed disappearance of iESCs within the myocardium, whereas 5-bromo-2'-deoxyuridine assays revealed de novo in vivo cardiomyocyte DNA synthesis. Microarray gene expression profiling demonstrated an early increase in metabolism, DNA proliferation, and chromatin remodeling pathways, and a decrease in fibrosis and inflammatory gene expression compared with media-treated controls.
CONCLUSIONS: As a result of irradiation before injection, ex vivo and in vivo iESC existence is transient, yet iESCs provide a significant improvement in cardiac function after acute myocardial infarction. The mechanism(s) of action of iESCs seems to be related to cell-cell exchange, paracrine factors, and a scaffolding effect between iESCs and neighboring host cardiomyocytes.

Entities:  

Mesh:

Year:  2012        PMID: 22914647     DOI: 10.1161/CIRCRESAHA.111.262584

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  10 in total

1.  A reliable and economical method for gaining mouse embryonic fibroblasts capable of preparing feeder layers.

Authors:  Guangming Jiang; Xiaoju Wan; Ming Wang; Jianhua Zhou; Jian Pan; Baolong Wang
Journal:  Cytotechnology       Date:  2015-01-18       Impact factor: 2.058

2.  Importance of cell-cell contact in the therapeutic benefits of cardiosphere-derived cells.

Authors:  Yucai Xie; Ahmed Ibrahim; Ke Cheng; Zhijun Wu; Wenbin Liang; Konstantinos Malliaras; Baiming Sun; Weixin Liu; Deliang Shen; Hee Cheol Cho; Taosheng Li; Lin Lu; Guoping Lu; Eduardo Marbán
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

3.  Evidence for Mechanisms Underlying the Functional Benefits of a Myocardial Matrix Hydrogel for Post-MI Treatment.

Authors:  Jean W Wassenaar; Roberto Gaetani; Julian J Garcia; Rebecca L Braden; Colin G Luo; Diane Huang; Anthony N DeMaria; Jeffrey H Omens; Karen L Christman
Journal:  J Am Coll Cardiol       Date:  2016-03-08       Impact factor: 24.094

4.  Returns of the living dead: therapeutic action of irradiated and mitotically inactivated embryonic stem cells.

Authors:  Joseph D Gold; Joseph C Wu
Journal:  Circ Res       Date:  2012-10-26       Impact factor: 17.367

Review 5.  Stem cell stimulation of endogenous myocyte regeneration.

Authors:  Brian R Weil; John M Canty
Journal:  Clin Sci (Lond)       Date:  2013-08       Impact factor: 6.124

6.  Long-Term Outcome of Administration of c-kit(POS) Cardiac Progenitor Cells After Acute Myocardial Infarction: Transplanted Cells Do not Become Cardiomyocytes, but Structural and Functional Improvement and Proliferation of Endogenous Cells Persist for at Least One Year.

Authors:  Xian-Liang Tang; Qianhong Li; Gregg Rokosh; Santosh K Sanganalmath; Ning Chen; Qinghui Ou; Heather Stowers; Greg Hunt; Roberto Bolli
Journal:  Circ Res       Date:  2016-02-02       Impact factor: 17.367

7.  Silica-coated magnetic nanoparticles labeled endothelial progenitor cells alleviate ischemic myocardial injury and improve long-term cardiac function with magnetic field guidance in rats with myocardial infarction.

Authors:  Bo-Fang Zhang; Hong Jiang; Jing Chen; Qi Hu; Shuo Yang; Xiao-Pei Liu
Journal:  J Cell Physiol       Date:  2019-04-14       Impact factor: 6.384

8.  Bioluminescent imaging of genetically selected induced pluripotent stem cell-derived cardiomyocytes after transplantation into infarcted heart of syngeneic recipients.

Authors:  Vera Lepperhof; Olga Polchynski; Klaus Kruttwig; Chantal Brüggemann; Klaus Neef; Florian Drey; Yunjie Zheng; Justus P Ackermann; Yeong-Hoon Choi; Thomas F Wunderlich; Mathias Hoehn; Jürgen Hescheler; Tomo Sarić
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

Review 9.  The Evolution of the Stem Cell Theory for Heart Failure.

Authors:  Jean-Sébastien Silvestre; Philippe Menasché
Journal:  EBioMedicine       Date:  2015-11-05       Impact factor: 8.143

Review 10.  Stem Cell Therapy for the Heart: Blind Alley or Magic Bullet?

Authors:  Arne A N Bruyneel; Apurv Sehgal; Sophia Malandraki-Miller; Carolyn Carr
Journal:  J Cardiovasc Transl Res       Date:  2016-08-19       Impact factor: 4.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.